MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

May 2008


Letters to the Editor

Drug Utilization Evaluation

Prescribing Trends with Daptomycin (Cubicin) for the Treatment of Gram-Positive Infections

The injectable agent daptomycin, when prescribed according to approved guidelines, can be a welcome option for treating some multiresistant, gram-positive infections that have become increasingly prevalent.
Noreen H. Chan Tompkins, PharmD, and Stephen J. Harnicar, PharmD

Effect of Persistence with Drug Therapy on the Risk of Myocardial Re-infarction

Medicaid patients who continued with their initial MI-preventive therapy (beta blockers, calcium-channel blockers, or statins) after a heart attack were more likely to avoid re-infarction and death.
Fadia T. Shaya, PhD, MPH; Anna Gu, PhD, MS; and Xia Yan, MS

Meeting Highlights

American College of Cardiology 57th Scientific Sessions, 2008

Presentations cover comparisons of ezetimibe/simvastatin (Vytorin) versus Zocor alone for reducing cholesterol; amlodipine/atorvastatin (Caduet) for preventing myocardial ischemia; extended-release niacin/laropiprant (Cordaptive) for lowering lipid levels; and bivalirudin (Angiomax) versus unfractionated heparin for reducing bleeding after coronary procedures.
Reuben B. David

Pharmaceutical Approval Update

Topics include bendamustine (Treanda) for chronic lymphocytic leukemia, ­hepatitis B immune globulin (HepaGam B) to prevent hepatitis B infection following liver transplantation, and a fibrin sealant (Artiss) used in skin graft surgery for burn patients.
Marvin M. Goldenberg, PhD, RPh, MS



Open Public Hearing No. 4: My Fight for Nonprescription Mevacor

David Nash, MD, MBA, recounts his testimony before the FDA in which he supported bringing lovastatin (Mevacor) over the counter.
David Nash, MD, MBA

Medication Errors

Template for Disaster? Fatal Injection into Wrong Port of Implanted Infusion Pump

Matthew Grissinger, RPh, FASCP, describes the potential for fatal mishaps when the wrong port is selected during the refilling of implantable infusion pumps used for ­delivering opiates.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Medicare Adopts e-Prescribing Standards for Formularies – But More Tweaking Needed

Stephen Barlas delves into some of the shortcomings of Medicare’s adoption of new electronic prescribing standards for formularies.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From Aplenzin to Treximet, P&T presents the latest studies and information about FDA approvals, new indications, recalls, and industry updates.

Drug Forecast

Omega-3-acid Ethyl Esters (Lovaza) for Severe Hypertriglyceridemia

Omega-3-acid ethyl esters (Lovaza) are now available for treating patients with severe hypertriglyceridemia.
Renee R. Koski, PharmD, CACP